Sign in
Not yet recruitingNo phase

A Blinded Randomized Clinical Study of RefluxStop™ Compared With Nissen Fundoplication in the Treatment of GERD

Key facts

Who runs it
Implantica CE Reflux Ltd.
Where
Austria, Germany, and Switzerland4 sites in 3 countriesChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
200 people, planned
Started
1 Aug 2025
Expected to end
1 Dec 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • RefluxStop™ implantation
  • Nissen fundoplication
Record updated
4 June 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Willing and able to provide informed consent and to participate in the clinical investigation
  • Age ≥ 18 years or according to local legal age of adulthood at the location of the test site if older
  • Documented GERD present for ≥ 12 months. Typical symptoms are defined as heartburn, which is a burning sensation often presented as a substernal pain
  • 24-hour pH monitoring proven GERD with pH measurement, off PPI therapy for at least 7 days prior to testing. (Total distal esophageal pH must be < 4 for ≥ 4.5% of time during a 24-hour monitoring)
  • Suitable to undergo general anesthesia and is a suitable laparoscopic surgery candidate as determined by the investigator

Who cannot take part

  • Manometry verified lack of or moderate or severe weak peristalsis in esophagus with DCI <300 or pathologic LOS function including hypercontractability, spasm or pathologic nonrelaxing functionality (the latter defined as coordinated swallows in less than 70% of wet swallows or median IRP>15mmHg). Hypercontractability defined as DCI >8'000 or pressure >45 mmHg. Thus, excluding from the study the rare diseases achalasia, scleroderma, and nutcracker esophagus, however, including mild esophageal motility disorder patients with mildly weak peristalsis
  • History of bariatric or anti-reflux surgery
  • Known sensitivity or allergies to silicone materials
  • Subjects that are unable to comply with the clinical investigation requirements (for example due to major psychiatric disorder or are considered otherwise unsuitable for participation in the clinical investigation according to the investigator's judgement)
  • > 8 cm sliding hernia and paraesophageal hernia; no mesh is allowed
  • Female subjects who are pregnant or nursing
  • Intraoperative findings determined by the investigator that may result in unfavorable conduct of the clinical investigation procedure (as outlined in the IFU)

Where is this trial?

It has sites in 3 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study will evaluate if the RefluxStop™ device will treat your acid reflux and improve your symptoms and how it compares to the standard surgical treatment for GERD, the Nissen fundoplication.

The 2 groups in the trial

  • RefluxStop™ device implantationExisting treatment, for comparison

    Standard surgical technique for implantation RefluxStop™, as described in the Instructions for Use

    Treatment: RefluxStop™ implantation

  • Nissen fundoplication surgeryExisting treatment, for comparison

    Standard surgical technique of Nissen fundoplication

    Treatment: Nissen fundoplication

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Blinded Randomized Clinical Investigation of RefluxStop™ Compared With Nissen Fundoplication in the Treatment of Gastroesophageal Reflux Disease (GERD).
Record updated
4 June 2025